Laboratory Safety of Dupilumab in Patients Aged 6 to 11 Years with Severe Atopic Dermatitis: Results from a Phase 3 Clinical Trial
Article full text
The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days.
For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021